DOI: 10.1055/s-00044881

Journal of Laboratory Physicians

References

Chiorean EG, Ramasubbaiah R, Yu M. et al.
Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.

Oncologist 2012;
17 (01) 13

Download Bibliographical Data

Access:
Access: